Flossbach Von Storch SE Takes Position in Ralliant Corporation $RAL

Flossbach Von Storch SE bought a new position in shares of Ralliant Corporation (NYSE:RAL) in the 2nd quarter, Holdings Channel reports. The fund bought 3,021,324 shares of the company’s stock, valued at approximately $222,460,000. Ralliant makes up 1.0% of Flossbach Von Storch SE’s holdings, making the stock its 27th biggest position.

A number of other institutional investors and hedge funds have also recently bought and sold shares of RAL. Cetera Investment Advisers acquired a new stake in Ralliant in the second quarter valued at $700,000. Russell Investments Group Ltd. acquired a new stake in shares of Ralliant in the second quarter valued at approximately $1,465,000. EverSource Wealth Advisors LLC purchased a new position in shares of Ralliant during the 2nd quarter worth approximately $39,000. First Trust Advisors LP acquired a new position in shares of Ralliant during the 2nd quarter worth approximately $2,013,000. Finally, Federated Hermes Inc. purchased a new stake in Ralliant in the 2nd quarter valued at approximately $326,000.

Ralliant Stock Performance

Shares of RAL stock opened at $66.56 on Thursday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a market capitalization of $7.36 billion, a price-to-earnings ratio of -6.13, a price-to-earnings-growth ratio of 2.58 and a beta of 1.60. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The company has a 50 day moving average price of $69.02 and a 200 day moving average price of $55.79.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.05. The company had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Sell-side analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s dividend payout ratio is currently -1.84%.

Insider Transactions at Ralliant

In related news, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer owned 251,967 shares of the company’s stock, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the transaction, the senior vice president owned 31,668 shares in the company, valued at $2,280,096. The trade was a 16.07% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on RAL. Royal Bank Of Canada raised their price target on Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a research report on Friday, July 31st. TD Cowen lifted their price objective on Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Oppenheimer boosted their target price on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Citigroup upped their target price on shares of Ralliant from $81.00 to $82.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, Vertical Research cut shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.